These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 7776837)

  • 1. An efficient new cannabinoid antiemetic in pediatric oncology.
    Abrahamov A; Abrahamov A; Mechoulam R
    Life Sci; 1995; 56(23-24):2097-102. PubMed ID: 7776837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of the emetogenic potential of intrathecal chemotherapy and response to prophylactic treatment with ondansetron.
    Holdsworth MT; Raisch DW; Winter SS; Chavez CM
    Support Care Cancer; 1998 Mar; 6(2):132-8. PubMed ID: 9540172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective evaluation of delta-9-tetrahydrocannabinol as an antiemetic in patients receiving adriamycin and cytoxan chemotherapy.
    Chang AE; Shiling DJ; Stillman RC; Goldberg NH; Seipp CA; Barofsky I; Rosenberg SA
    Cancer; 1981 Apr; 47(7):1746-51. PubMed ID: 6261926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nabilone: an alternative antiemetic for cancer chemotherapy.
    Dalzell AM; Bartlett H; Lilleyman JS
    Arch Dis Child; 1986 May; 61(5):502-5. PubMed ID: 3013104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of chemotherapy-induced emesis and evaluation of a reduced-dose intravenous ondansetron regimen in pediatric outpatients with leukemia.
    Holdsworth MT; Raisch DW; Duncan MH; Chavez CM; Leasure MM
    Ann Pharmacother; 1995 Jan; 29(1):16-21. PubMed ID: 7711340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review of cannabinoids and their antiemetic effectiveness.
    Vincent BJ; McQuiston DJ; Einhorn LH; Nagy CM; Brames MJ
    Drugs; 1983 Feb; 25 Suppl 1():52-62. PubMed ID: 6301800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapy induced nausea and emesis in pediatric cancer patients: external validity of child and parent emesis ratings.
    Tyc VL; Mulhern RK; Fairclough D; Ward PM; Relling MV; Longmire W
    J Dev Behav Pediatr; 1993 Aug; 14(4):236-41. PubMed ID: 8408666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. delta 9-Tetrahydrocannabinol (THC) as an antiemetic in patients treated with cancerchemotherapy; a double-blind cross-over trial against placebo.
    Kluin-Neleman JC; Neleman FA; Meuwissen OJ; Maes RA
    Vet Hum Toxicol; 1979 Oct; 21(5):338-40. PubMed ID: 516362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. delta 9-Tetrahydrocannabinol for refractory vomiting induced by cancer chemotherapy.
    Lucas VS; Laszlo J
    JAMA; 1980 Mar; 243(12):1241-3. PubMed ID: 6244418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of tetrahydrocannabinol in patients refractory to standard antiemetic therapy.
    McCabe M; Smith FP; Macdonald JS; Woolley PV; Goldberg D; Schein PS
    Invest New Drugs; 1988 Sep; 6(3):243-6. PubMed ID: 2847994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delta-9-tetrahydrocannabinol in cancer chemotherapy: research problems and issues.
    Carey MP; Burish TG; Brenner DE
    Ann Intern Med; 1983 Jul; 99(1):106-14. PubMed ID: 6305249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of combined doses of Δ(9)-tetrahydrocannabinol (THC) and cannabidiolic acid (CBDA) on acute and anticipatory nausea using rat (Sprague- Dawley) models of conditioned gaping.
    Rock EM; Limebeer CL; Parker LA
    Psychopharmacology (Berl); 2015 Dec; 232(24):4445-54. PubMed ID: 26381155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nausea and vomiting: Therapeutic orphans of pediatric oncology.
    Bernhardt MB
    Pediatr Blood Cancer; 2017 Oct; 64(10):. PubMed ID: 28561924
    [No Abstract]   [Full Text] [Related]  

  • 14. Delata-9-tetrahydrocannabinol as an antiemetic in cancer patients receiving high-dose methotrexate. A prospective, randomized evaluation.
    Chang AE; Shiling DJ; Stillman RC; Goldberg NH; Seipp CA; Barofsky I; Simon RM; Rosenberg SA
    Ann Intern Med; 1979 Dec; 91(6):819-24. PubMed ID: 293141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. delta 9-tetrahydrocannabinol in clinical oncology.
    Poster DS; Penta JS; Bruno S; Macdonald JS
    JAMA; 1981 May 22-29; 245(20):2047-51. PubMed ID: 6262541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delta-9-tetrahydrocannabinol as an antiemetic for patients receiving cancer chemotherapy. A comparison with prochlorperazine and a placebo.
    Frytak S; Moertel CG; O'Fallon JR; Rubin J; Creagan ET; O'Connell MJ; Schutt AJ; Schwartau NW
    Ann Intern Med; 1979 Dec; 91(6):825-30. PubMed ID: 517882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiemetic efficacy of levonantradol compared to delta-9-tetrahydrocannabinol for chemotherapy-induced nausea and vomiting.
    Citron ML; Herman TS; Vreeland F; Krasnow SH; Fossieck BE; Harwood S; Franklin R; Cohen MH
    Cancer Treat Rep; 1985 Jan; 69(1):109-12. PubMed ID: 2981616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Availability and approval of cannabis-based medicines for chronic pain management and palliative/supportive care in Europe: A survey of the status in the chapters of the European Pain Federation.
    Krcevski-Skvarc N; Wells C; Häuser W
    Eur J Pain; 2018 Mar; 22(3):440-454. PubMed ID: 29134767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of adjuvant lorazepam with granisetron on chemotherapy-induced nausea and vomiting in pediatric patients with acute lymphoblastic leukemia.
    Ono A; Kishimoto K; Hasegawa D; Goldman RD; Kosaka Y
    Support Care Cancer; 2019 Mar; 27(3):895-899. PubMed ID: 30066198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A retrospective review of antiemetic use for chemotherapy-induced nausea and vomiting in pediatric oncology patients at a tertiary care center.
    Aseeri M; Mukhtar A; Al Khansa S; Elimam N; Jastaniah W
    J Oncol Pharm Pract; 2013 Jun; 19(2):138-44. PubMed ID: 23034405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.